4//SEC Filing
Cross Shawn 4
Accession 0001437749-25-005850
CIK 0000922247other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 11:44 AM ET
Size
4.9 KB
Accession
0001437749-25-005850
Insider Transaction Report
Form 4
Cross Shawn
Director
Transactions
- Award
Common Stock
2025-02-27+28,597→ 136,346 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
Related Parties
1- filerCIK 0001734779
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 11:44 AM ET
- Size
- 4.9 KB